Announce Date | 05/20/2025 |
EPS Normalized Actual | $0.34 (Miss by $-0.08) |
EPS GAAP Actual | $0.34 (Miss by $-0.08) |
Revenue Actual | $5.395B |
Revenue Surprise | Beat by $5395M |
Announce Date | 09/30/2025 (Pre-Market) |
EPS Normalized Estimate | $4.59596 |
EPS GAAP Estimate | $4.59596 |
Revenue Estimate | $7.447836838B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 18.22753 | 1.82 | 16.27799 | 20.17707 | 2 |
Dec 2026 | 0 | INF | 0 | 0 | 4 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.9 | 0.34559 | 5.395B | 2.17% | -235.4M |
FQ4 2024 (Dec 2024) | 0.16 | -3.27143 | 6.023B | 7.27% | -8125M |
FQ3 2024 (Sep 2024) | 0 | -1.54141 | 6.442B | 2.39% | -6000.5M |
FQ2 2024 (Jun 2024) | 0.47 | 0.47 | 6.148B | 10.05% | 6148M |
FQ4 2009 (Dec 2009) | -0.65 | -0.65 | 0B | NAN% | 0M |
FQ1 2024 (Mar 2024) | 2.1 | 2.1 | 5.278B | 15.12% | 5278M |
FQ4 2023 (Dec 2023) | 2.3 | 2.3 | 5.585B | 33.64% | 5585M |
FQ3 2023 (Sep 2023) | 4.2 | 4.2 | 6.288B | 34.91% | 6288M |
FQ4 Announce Date
09/30/2025 (Pre-Market)
Consensus EPS Estimates
4.59596
Consensus Revenue Estimates
7.447836838B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 3.42779 | -- | 3.05101 | 4.18577 | 1 |
FQ3 2027 (Sep 2027) | 5.29019 | -- | 4.7087 | 6.45999 | 1 |
FQ2 2027 (Jun 2027) | 4.29577 | -- | 3.82359 | 5.24568 | 1 |
FQ1 2027 (Mar 2027) | 2.6327 | -- | 2.34332 | 3.21486 | 1 |
FQ4 2026 (Dec 2026) | 3.8084 | -- | 3.7858 | 3.8239 | 0 |
FQ3 2026 (Sep 2026) | 5.16621 | -- | 4.97836 | 5.27345 | 0 |
FQ2 2026 (Jun 2026) | 4.6913 | -- | 4.52072 | 4.78868 | 0 |
FQ1 2026 (Mar 2026) | 2.5698 | -12.85 | 2.55455 | 2.58026 | 0 |
FQ4 2025 (Dec 2025) | 3.02959 | 94.72 | 3.01161 | 3.04192 | 1 |
FQ3 2025 (Sep 2025) | 4.59596 | -- | 4.42885 | 4.69136 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 7.08B | -- | 6.48B | 8.28B | 2 |
FQ3 2027 (Sep 2027) | 7.88B | -- | 7.22B | 9.22B | 2 |
FQ2 2027 (Jun 2027) | 7.19B | -- | 6.58B | 8.41B | 2 |
FQ1 2027 (Mar 2027) | 5.97B | -- | 5.47B | 6.99B | 2 |
FQ4 2026 (Dec 2026) | 6.15B | -- | 6.12B | 6.17B | 1 |
FQ3 2026 (Sep 2026) | 8.14B | -- | 7.92B | 8.27B | 1 |
FQ2 2026 (Jun 2026) | 7.49B | -- | 7.28B | 7.61B | 1 |
FQ1 2026 (Mar 2026) | 6.1B | 11.49 | 6.07B | 6.11B | 1 |
FQ4 2025 (Dec 2025) | 5.97B | -0.85 | 5.94B | 5.99B | 0 |
FQ3 2025 (Sep 2025) | 7.45B | 13.51 | 7.24B | 7.57B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
4
Revenue # of Misses
3
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.55441 | 2.9 | 0.34559 | 11.92% |
FQ4 2024 (Dec 2024) | 3.43143 | 0.16 | -3.27143 | -2044.64% |
FQ3 2024 (Sep 2024) | 1.54141 | 0 | -1.54141 | -INF% |
FQ2 2024 (Jun 2024) | 0.47 | 0.47 | 100% | |
FQ4 2009 (Dec 2009) | -0.65 | -0.65 | 100% | |
FQ1 2024 (Mar 2024) | 2.1 | 2.1 | 100% | |
FQ4 2023 (Dec 2023) | 2.3 | 2.3 | 100% | |
FQ3 2023 (Sep 2023) | 4.2 | 4.2 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $5.63B | $5.4B | $-235.4M | -4.36% |
FQ4 2024 (Dec 2024) | $14.15B | $6.02B | $-8125M | -134.9% |
FQ3 2024 (Sep 2024) | $12.44B | $6.44B | $-6000.5M | -93.15% |
FQ2 2024 (Jun 2024) | $0B | $6.15B | $6148M | 100% |
FQ4 2009 (Dec 2009) | $0B | $0B | $0M | NAN% |
FQ1 2024 (Mar 2024) | $0B | $5.28B | $5278M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.59B | $5585M | 100% |
FQ3 2023 (Sep 2023) | $0B | $6.29B | $6288M | 100% |